La traduction est en cours. L’article original est affiché.
Healthcare stocks may struggle to gain momentum as Democrats prepare to take over Congress. Jared Holz, who covers healthcare for Mizuho, says the outlook for the sector is uncertain because of likely gridlock between lawmakers. "The next couple of years I really can't see too much happening," the firm's sector specialist told CNBC's " Fast Money " on Wednesday. "I'm not sure you want to own everything, but you can pick and choose the names… Pharma is trading more expensive than tech for the first time in 20 years. So, I backed away from pharma. I would look at medtech." The State Street Health Care Select ETF (XLV) jumped 3% a day after Election Day.
Nous affichons publiquement l'idee principale. Creez un compte gratuit pour lire l'article complet, l'enregistrer, le commenter et le relier au contexte marches et OSINT.